Novel Strategy with Gemcitabine for Advanced Pancreatic Cancer

<table>Contribution of thymidylate synthase (TS) in metabolic pathway of gemcitabine. For explanation of symbols and metabolic routes, see text. hENT1, human equilibrative nucleoside transporter; dCK, deoxycytidine kinase; RR, ribonucleotide reductase; 5′-NT, 5′-nucleotidase; CDA, cytidine deaminase.</table>

International Scholarly Research Notices

fig4

Figure 4

Figure 4: Novel Strategy with Gemcitabine for Advanced Pancreatic Cancer 